NL-OMON52394招募中不适用
The HF-AF ENERGY Trial: Attenuate atrial fibrillation with nicotinamide riboside (niagen) - The HF-AF ENERGY Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients diagnosed with paroxysmal or persistent AF
- •Left ventricle function <=40%
- •Implantable cardiac device (ICD) equipped with rhythm monitoring software
- •Ischemic and/or non-ischemic cardiomyopathy
- •Aged between 18-90 years
排除标准
- •Permanent AF
- •Hemodynamic instability
- •Absence of atrial sensing
- •Malabsorption diseases
- •Metabolic diseases
- •Inflammatory disease
研究者
相似试验
已完成
4 期
LEAF - Low Energy In Atrial FibrillationAtrial TachyarrhythmiaAtrial FibrillationNCT00157781Medtronic Cardiac Rhythm and Heart Failure237
已完成
不适用
AFIRE Study: Atrial Fibrillation and Ischemic events with Rivaroxaban in patiEnts with stable coronary artery disease Studyon-valvular atrial fibrillationJPRN-UMIN000016612Japan Cardiovascular Research Foundation2,200
已完成
1 期
The effect of medical therapy for atrial fibrillation after cardiovascular surgeryatrial fibrillation after cardiovascular surgeryJPRN-UMIN000020505Department of Surgery, Yokohama City University400
尚未招募
不适用
A study on safety and efficacy of atrial fibrillation ablation using ThermoCoolTM SmartTouchTM Surround Flow catheter: comparison with ThermoCool TM SmartTouch TM (thermo cool smart touch) catheteratrial fibrillationJPRN-UMIN000025570Hirosaki University Graduate School of Medicine60
已完成
3 期
Effect of hANP for prevention of atrial fibrillation after CABG: a randomised controlled trialJPRN-UMIN000003958ihon University school of medicine700